Paul Travers

Dr. Paul Travers

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Brain, Behavior, and Immunity
Verified
Journal Article
Open access
APAdria Prieto-Hinojosa
Adria Prieto-Hinojosa
AKAndrea Knight
Andrea Knight
CCClaude Compton
Claude Compton
MGMichael Gleeson
Michael Gleeson
PTPaul Travers
Paul Travers
Athletes undergoing intensive training schedules have chronic exposure to stress-induced hormones such as cortisol that can depress immune function. We compared the circulating levels of T cell receptor excision circles (TREC), a marker of recent thymic emigrants, as well as the levels of naïve and memory subsets in a group of elite endurance athletes and in controls. The athletes showed a reduction in absolute numbers of naïve T cells, particularly in CD4 T cells. In contrast, memory cells were increased. TREC levels in the athletes were significantly reduced compared to age-matched controls. Such changes resemble premature ageing of the T cell component of the immune system. Since thymic production of T cells naturally decline with age, these results raise the concern that prolonging high intensity exercise into the 4th decade of life may have deleterious consequences for athletes' health.

Verified
Journal Article
Open access
PDF file
LFLetícia Fracaro
Letícia Fracaro
ASAlexandra Cristina Senegaglia
Alexandra Cristina Senegaglia
RHRoberto Herai
Roberto Herai
ALAmanda Leitolis
Amanda Leitolis
LBLidiane M. Boldrini-Leite
Lidiane M. Boldrini-Leite
ACAlejandro Correa
Alejandro Correa
Mesenchymal stromal cells (MSCs) can self-renew, differentiate into specialised cells and have different embryonic origins—ectodermal for dental pulp-derived MSCs (DPSCs) and mesodermal for adipose tissue-derived MSCs (ADSCs). Data on DPSCs adipogenic differentiation potential and timing vary, and the lack of molecular and genetic information prompted us to gain a better understanding of DPSCs adipogenic differentiation potential and gene expression profile. While DPSCs differentiated readily along osteogenic and chondrogenic pathways, after 21 days in two different types of adipogenic induction media, DPSCs cultures did not contain lipid vacuoles and had low expression levels of the adipogenic genes proliferator-activated receptor gamma (PPARG), lipoprotein lipase (LPL) and CCAAT/enhancer-binding protein alpha (CEBPA). To better understand this limitation in adipogenesis, transcriptome analysis in undifferentiated DPSCs was carried out, with the ADSC transcriptome used as a positive control. In total, 14,871 transcripts were common to DPSCs and ADSCs, some were unique (DPSCs: 471, ADSCs: 1032), and 510 were differentially expressed genes. Detailed analyses of overrepresented transcripts showed that DPSCs express genes that inhibit adipogenic differentiation, revealing the possible mechanism for their limited adipogenesis.

14 April 2022 in Cells
Verified
Journal Article
Open access
PDF file
BZBernardo Zoehler
Bernardo Zoehler
LFLetícia Fracaro
Letícia Fracaro
LBLidiane Maria Boldrini-Leite
Lidiane Maria Boldrini-Leite
JSJosé Samuel da Silva
José Samuel da Silva
PTPaul Travers
Paul Travers
ASAlexandra Cristina Senegaglia
Alexandra Cristina Senegaglia
Mesenchymal stromal cells (MSCs) have been used in immunosuppressive therapy due to their therapeutic effects, with the HLA-G molecule seeming to play a fundamental role. This work evaluated alternative MSC sources to bone marrow (BM), namely, umbilical cord tissue (UC), adipose tissue (AD) and dental pulp tissue (DP), and the influence of interferon-γ (IFN-γ) and hypoxia on the cultivation of these cells for use in immunosuppression therapies. Expression of costimulatory markers CD40, CD80 and CD86 and immunosuppressive molecules CD152 and HLA-G was analyzed. Lymphocyte inhibition assays were also performed. Sequencing of the HLA-G gene from exons 1 to 5 was performed using next-generation sequencing to determine the presence of alleles. UC-derived MSCs (UCMSCs) expressed higher CD152 and HLA-G1 under standard cultivation. UCMSCs and DP-derived MSCs (DPSCs) secreted similar levels of HLA-G5. All MSC sources inhibited the proliferation of peripheral blood mononuclear cells (PBMCs); growth under regular versus hypoxic conditions resulted in similar levels of inhibition. When IFN-γ was added, PBMC growth was inhibited to a lesser extent by UCMSCs. The HLA-G*01:04:01:01 allele appears to generate a more efficient MSC response in inhibiting lymphocyte proliferation. However, the strength of this conclusion was limited by the small sample size. UCMSCs are an excellent alternative to BM in immunosuppressive therapy: they express high concentrations of inhibitory molecules and can be cultivated without stimuli, which minimizes cost.

4 May 2009 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
SRSylvie Rusakiewicz
Sylvie Rusakiewicz
GAGeraldine Aubert
Geraldine Aubert
RCRichard E. Clark
Richard E. Clark
Jose Alejandro MadrigalJose Alejandro Madrigal
Jose Alejandro Madrigal
ADAnthony I. Dodi
Anthony I. Dodi
PTPaul Travers
Paul Travers

1 January 2009
Verified
Book Chapter
Closed access
KMKenneth M. Murphy
Kenneth M. Murphy
PTPaul Travers
Paul Travers
MWMark Walport
Mark Walport